FibroBiologics, Inc. Earnings Per Share (Basic)
FibroBiologics, Inc. (FBLG) reported Earnings Per Share (Basic) of -$0.66 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-07-31
- FibroBiologics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.66.
- FibroBiologics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$1.33.
- FibroBiologics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.13.
- FibroBiologics, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$2.41, a 8133.33% decline year-over-year.
- FibroBiologics, Inc. earnings per share, basic for fiscal 2025 was -$0.42.
- FibroBiologics, Inc. earnings per share, basic for fiscal 2024 was -$0.34.
- FibroBiologics, Inc. earnings per share, basic for fiscal 2023 was -$0.68.
- FibroBiologics, Inc. earnings per share, basic for fiscal 2022 was -$0.18.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.66 10-Q · filed 2026-07-31 | -$1.81 10-Q · filed 2026-07-31 | ||||
| 2026-03-31 | -$1.33 10-Q · filed 2026-04-30 | |||||
| 2025-12-31 | -$0.42 10-K · filed 2026-02-24 | |||||
| 2025-09-30 | -$0.13 10-Q · filed 2025-10-31 | -$0.39 10-Q · filed 2025-10-31 | ||||
| 2025-06-30 | -$2.41 10-Q · filed 2026-07-31 | -$0.12 10-Q · filed 2025-07-31 | -$5.11 10-Q · filed 2026-07-31 | -$0.26 10-Q · filed 2025-07-31 | -$1.01 derived: net income ÷ weighted average shares · filed 2026-07-31 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-07-31 |
| 2025-03-31 | -$2.71 10-Q · filed 2026-04-30 | -$0.14 10-Q · filed 2025-05-14 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-04-30 | |
| 2024-12-31 | -$0.09 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$0.34 10-K · filed 2026-02-24 | ||
| 2024-09-30 | -$0.01 10-Q · filed 2025-10-31 | $0.01 derived: net income ÷ weighted average shares · filed 2025-10-31 | -$0.25 10-Q · filed 2025-10-31 | -$0.57 derived: net income ÷ weighted average shares · filed 2025-10-31 | ||
| 2024-06-30 | $0.03 10-Q · filed 2025-07-31 | -$0.24 10-Q · filed 2025-07-31 | -$0.56 derived: net income ÷ weighted average shares · filed 2025-07-31 | -$0.65 derived: net income ÷ weighted average shares · filed 2025-07-31 | ||
| 2024-03-31 | -$0.27 10-Q · filed 2025-05-14 | -$0.61 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$0.70 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$0.78 derived: net income ÷ weighted average shares · filed 2025-05-14 | ||
| 2023-12-31 | -$0.34 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.42 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.50 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.68 10-K · filed 2025-03-31 | ||
| 2023-09-30 | -$0.08 10-Q · filed 2024-11-12 | -$0.15 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.33 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | -$0.08 10-Q · filed 2024-08-07 | -$0.25 10-Q · filed 2024-08-07 | ||||
| 2023-03-31 | -$0.18 10-Q · filed 2024-05-14 | |||||
| 2022-12-31 | -$0.18 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 |